S. Garciaz

Efficacy of chemotherapy or chemo‐anti‐PD‐1 combination after failed anti‐PD‐1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers

L. Obéric, L. Ysebaert, T. Filleron, 2018, American journal of hematology.

Lenalidomide for the treatment of B-cell lymphoma

R. Bouabdallah, D. Coso, S. Garciaz, 2016, Expert opinion on investigational drugs.

Partial Response at Completion of Bortezomib-Thalidomide-Dexamethasone (VTd) Induction Regimen Upfront in Multiple Myeloma Does Not Preclude Response to VTd in Consolidation

B. Pégourié, P. Moreau, X. Leleu, 2014, Journal of Cancer.

Tandem autologous-allogeneic stem cell transplantation as a feasible and effective procedure in high-risk lymphoma patients

R. Bouabdallah, A. Santoro, D. Blaise, 2015, Haematologica.

Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma

B. Pégourié, P. Moreau, X. Leleu, 2013, Leukemia.

Brentuximab vedotin followed by allogeneic transplantation as salvage regimen in patients with relapsed and/or refractory Hodgkin's lymphoma

R. Bouabdallah, B. Chetaille, D. Blaise, 2014, Hematological oncology.